03317 Relative Valuation
03317's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, 03317 is overvalued; if below, it's undervalued.
Historical Valuation
XUNCE (03317) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of XUNCE (03317) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：47.90
Fair
0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
XUNCE. (03317) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
XUNCE. (03317) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
XUNCE. (03317) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
XUNCE. (03317) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
XUNCE. (03317) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
XUNCE (03317) has a current Price-to-Book (P/B) ratio of 8.92. Compared to its 3-year average P/B ratio of 8.93 , the current P/B ratio is approximately -0.15% higher. Relative to its 5-year average P/B ratio of 8.93, the current P/B ratio is about -0.15% higher. XUNCE (03317) has a Forward Free Cash Flow (FCF) yield of approximately -1.39%. Compared to its 3-year average FCF yield of -1.38%, the current FCF yield is approximately 0.12% lower. Relative to its 5-year average FCF yield of -1.38% , the current FCF yield is about 0.12% lower.
8.92
P/B
Median3y
8.93
Median5y
8.93
-1.39
FCF Yield
Median3y
-1.38
Median5y
-1.38
Performance Decomposition
1Y
3Y
5Y
Market capitalization of 03317 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 03317 in the past 1 year is driven by Unknown.
People Also Watch
NVDA
NVIDIA Corp
184.91USD
-2.22%
META
Meta Platforms Inc
643.9USD
-0.74%
XOM
Exxon Mobil Corp
123.33USD
4.08%
WMT
Walmart Inc
112.75USD
0.03%
AVGO
Broadcom Inc
330.72USD
-3.72%
ORCL
Oracle Corp
188.91USD
-2.04%
AAPL
Apple Inc
257.05USD
-1.26%
AMZN
Amazon.com Inc
245.78USD
1.75%
TSLA
Tesla Inc
434.5799USD
0.73%
MSFT
Microsoft Corp
476.105USD
-1.52%
Frequently Asked Questions
Is XUNCE (03317) currently overvalued or undervalued?
XUNCE (03317) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of XUNCE (03317) is between to according to relative valuation methord.
What is XUNCE (03317) fair value?
03317's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of XUNCE (03317) is between to according to relative valuation methord.
How does 03317's valuation metrics compare to the industry average?
The average P/S ratio for 03317's competitors is , providing a benchmark for relative valuation. XUNCE Corp (03317) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for XUNCE (03317) as of Jan 08 2026?
As of Jan 08 2026, XUNCE (03317) has a P/B ratio of 8.92. This indicates that the market values 03317 at 8.92 times its book value.
What is the current FCF Yield for XUNCE (03317) as of Jan 08 2026?
As of Jan 08 2026, XUNCE (03317) has a FCF Yield of -1.39%. This means that for every dollar of XUNCE’s market capitalization, the company generates -1.39 cents in free cash flow.
What is the current Forward P/E ratio for XUNCE (03317) as of Jan 08 2026?
As of Jan 08 2026, XUNCE (03317) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of XUNCE’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for XUNCE (03317) as of Jan 08 2026?
As of Jan 08 2026, XUNCE (03317) has a Forward P/S ratio of 0.00. This means the market is valuing 03317 at $0.00 for every dollar of expected revenue over the next 12 months.